| Trial ID: | L4887 |
| Source ID: | NCT01768208
|
| Associated Drug: |
Saxagliptin
|
| Title: |
Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Saxagliptin
|
| Outcome Measures: |
Primary: The primary objective of the study is to evaluate the changes in the metabolomic parameters before and after Saxagliptin treatment in type 2 diabetic patients., The primary objective of the study is to compare the different metabolomic profiling at baseline (before treatment) and at the end of the study drug administration(24 weeks) using a Liquid Chromatography-Mass Spectrometry (LC-MS) analysis., 24 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Jiao Tong University School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
569
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
|
| Start Date: |
2012-10
|
| Completion Date: |
2017-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-06-14
|
| Locations: |
Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01768208
|
